 |
카테고리 |
 |
|
|
3D Bioprinting 2014-2024: Applications, Markets, Players
|
|
발행사
|
IDTechEx
|
|
|
발행일
|
2015-11
|
|
분량
|
104 pages
|
|
서비스형태
|
Report
|
|
판매가격
|
|
 |
|
Table of Contents1. EXECUTIVE SUMMARY2. INTRODUCTION3. TECHNOLOGIES- 3.1. Inkjet based bioprinting
- 3.2. Syringe/extrusion based bioprinting
- 3.3. Magnetic levitation bioprinting
- 3.4. Laser assisted bioprinting
- 3.5. Valve-based bioprinting
- 3.6. Technology summary
4. APPLICATIONS- 4.1. Medical
- 4.1.1. Drug screening
- 4.1.2. Regenerative medicine
- 4.1.3. Tissue replacement (avascular)
- 4.1.4. Tissue replacement (vascular)
- 4.2. Dental
- 4.3. Consumer/personal product testing
- 4.4. Biosensors
- 4.5. Food and animal product bioprinting
- 4.6. Bioinks
- 4.6.1. Cells
- 4.6.2. Growth factors/proteins
- 4.6.3. Support material
5. MARKETS- 5.1. Market structure and key players
- 5.2. Value chain
- 5.3. Market barriers
- 5.4. Benefits
6. ROADMAP AND FORECASTS7. COMPANY INTERVIEWS- 7.1. Biobots
- 7.2. Digilab Inc
- 7.3. Dyson
- 7.4. EFESTO LLC
- 7.5. EPSRC
- 7.6. Fraunhofer Additive Manufacturing Alliance
- 7.7. Fripp Design Ltd
- 7.8. MicroFab Technologies Inc
- 7.9. n3D Biosciences, Inc
- 7.10. nScrypt Inc
- 7.11. Organovo
- 7.12. regenHU Ltd
- 7.13. TeVido Biodevices
- 7.14. Viridis 3D
IDTECHEX RESEARCH REPORTS AND CONSULTANCYTABLES- 3.1. Comparison of 3D bioprinting technology specifications
- 5.1. Incomes
- 5.2. Cost of replacing a human kidney
- 5.3. The benefits of 3D bioprinting
- 6.1. Addressable markets with market value for 3D bioprinting
- 6.2. Possible further opportunities for 3D bioprinting
- 6.3. Compound annual growth rates under multiple scenarios for diffusion
FIGURES- 1.1. 3D bioprinting forecast scenarios to 2024
- 1.2. The widening gap in transplant demand and supply
- 1.3. A roadmap for 3D bioprinting
- 2.1. 2D (left) vs. 3D (right) cultured cells
- 2.2. Scaffold built human bladders
- 2.3. Schematic of the 3D bioprinting process
- 2.4. Timeline for medical applications of 3D bioprinting
- 2.5. Organovo 3D bioprinter
- 3.1. 3D inkjet bioprinting
- 3.2. SWOT analysis for inkjet printing
- 3.3. Extrusion based bioprinting
- 3.4. SWOT analysis for extrusion/syringe based bioprinting
- 3.5. Magnetic levitation bioprinting
- 3.6. Magnetic levitation
- 3.7. SWOT analysis for magnetic levitation based bioprinting
- 3.8. Laser guided (left) and laser induced (right) bioprinting
- 3.9. SWOT analysis for laser-assisted bioprinting
- 3.10. SWOT analysis for valve-based bioprinting
- 4.1. Pipeline for drug discovery
- 4.2. Lung-on-a-chip (top) and gut-on-a-chip (bottom)
- 4.3. Human organ vascular network
- 4.4. Section of human skin
- 4.5. 3D bioprinted skin
- 4.6. The Dermal Repair Construct Printer
- 4.7. In situ bioprinting device
- 4.8. The BioPen
- 4.9. 3D bioprinted IVD (right)
- 4.10. 3D bioprinted heart valve
- 4.11. Human organ bioprinting (illustration only)
- 4.12. Illustration of a kidney vascular tree
- 4.13. 3D bioprinted living tooth
- 4.14. 3D bioprinted sensors
- 4.15. The Algaerium bioprinter
- 4.16. Growth factor mechanism
- 5.1. Number of 3D bioprinting companies as a function of time
- 5.2. 3D bioprinting company activities
- 5.3. Technologies employed by commercial organisations
- 5.4. Summary of product offerings of 3D bioprinting companies
- 5.5. Patent activity of 3D bioprinting companies
- 5.6. 3D bioprinting value chain
- 6.1. Roadmap for 3D bioprinting
- 6.2. Market forecasts for 3D bioprinting to 2024
|
|
|
 |
|
|
현재위치 : 
